Intrahospital transmission and infection control of Candida auris originating from a severely infected COVID-19 patient transferred abroad

被引:0
|
作者
Lee, E. H. [1 ]
Choi, M. H. [2 ,3 ]
Lee, K. H. [1 ]
Kim, D. [2 ,3 ]
Jeong, S. H. [2 ,3 ]
Song, Y. G. [1 ]
Han, S. H. [1 ,4 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea
[3] Yonsei Univ, Gangnam Severance Hosp, Res Inst Bacterial Resistance, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Dept Internal Med, Div Infect Dis, Coll Med, 211 Eonju ro, Seoul 06273, South Korea
关键词
Candida auris; COVID-19; Infection control; Intensive care unit; Outbreak; Tympanic thermometer; OUTBREAK; CHLORHEXIDINE; DISINFECTANTS;
D O I
10.1016/j.jhin.2023.10.017
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Intrahospital spread of Candida auris, which survives tenaciously in many environments, can cause sustained colonization and infection. A large outbreak of C. auris was experienced in the intensive care units (ICUs) at the study hospital during the coronavirus disease 2019 (COVID-19) pandemic.Methods: The index patient with severe COVID-19, who was transferred from Vietnam in January 2022, developed C. auris candidaemia 10 days after hospitalization. From mid June 2022 to January 2023, strengthened infection prevention and control (IPC) measures were implemented in three ICUs: (1) contact precautions and isolation (CPI) for C. auris-positive cases; (2) surveillance cultures including point-prevalence (N=718) for patients or close contacts or ICU-resident healthcare workers (HCWs); (3) intensive environmental disinfection with 10-fold diluted bleach; and (4) 2% chlorhexidine bathing for all ICU patients. Environmental cultures (ECx) on surfaces and shared objects (N=276) were conducted until early September 2022, when all ECx were negative.Results: Among 53 C. auris-positive patients between February 2022 and January 2023, invasive infections resulted in seven cases of candidaemia and one case of pneumonia. C. auris was isolated from reusable tympanic thermometers (TTMs) contaminated with earwax. The isolation rate of C. auris in ECx decreased from 6.8% in June 2022 to 2.0% in August 2022, and was no longer detected in TTMs. Colonization in HCWs was remarkably rare (0.5%). The number of C. auris-positive patients peaked in July (N=10) then decreased gradually. By January 2023, no C. auris were isolated in the ICU.Conclusion: Aggressive IPC measures with CPI, ECx and surveillance, decontamination of TTMs, and bathing were effective in successfully controlling this C. auris outbreak.(c) 2023 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:140 / 149
页数:10
相关论文
共 50 条
  • [21] Control of a Covid-19 outbreak on a leukemia and stem cell transplantation unit originating from a patient with a primary diagnosis of acute myeloid leukemia
    Greiner, J.
    Goetz, M.
    Malner-Wagner, W.
    Wendt, C.
    Enders, M.
    Durst, C.
    Michel, D.
    von Harsdorf, S.
    Jung, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 201 - 201
  • [22] COVID-19 and C. auris: A Case-Control Study from a Tertiary Care Center in Lebanon
    Allaw, Fatima
    Haddad, Sara F.
    Habib, Nabih
    Moukarzel, Pamela
    Naji, Nour Sabiha
    Kanafani, Zeina A.
    Ibrahim, Ahmad
    Zahreddine, Nada Kara
    Spernovasilis, Nikolaos
    Poulakou, Garyphallia
    Kanj, Souha S.
    [J]. MICROORGANISMS, 2022, 10 (05)
  • [23] Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward
    Williams, Ryan
    Tweed, John
    Rebolledo, Laura
    Khalid, Osman
    Agyeman, Josephine
    da Costa, Mariana Pinto
    [J]. BJPSYCH OPEN, 2021, 7 (04):
  • [24] Ophthalmoparesis from cranial nerve palsy in a patient with an acute COVID-19 infection
    Ilya Carpentier
    Stéphanie Lambrechts
    Sven Dekeyzer
    [J]. Neurological Sciences, 2023, 44 : 1499 - 1501
  • [25] Delirium in a Male Patient Following Recovery from Mild COVID-19 Infection
    Alsenaidi, Yasir I.
    Alsadhan, Khalid F.
    Alwhibi, Mohammed W.
    Almezail, Hessah I.
    Alrasheed, Abdullah A.
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (45A) : 169 - 173
  • [26] Ophthalmoparesis from cranial nerve palsy in a patient with an acute COVID-19 infection
    Carpentier, Ilya
    Lambrechts, Stephanie
    Dekeyzer, Sven
    [J]. NEUROLOGICAL SCIENCES, 2023, 44 (05) : 1499 - 1501
  • [27] Candida parapsilosis infection after double-lung transplantation in a patient with pulmonary fibrosis caused by COVID-19
    Chen, Hong-Rui
    Xue, Mei
    Zhou, Hao
    Wu, Yao-Gong
    Chen, Yan
    Chen, Wan-Xin
    [J]. CYTOJOURNAL, 2023, 20
  • [28] Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
    Lau, Emily S.
    McNeill, Jenna N.
    Paniagua, Samantha M.
    Liu, Elizabeth E.
    Wang, Jessica K.
    Bassett, Ingrid V.
    Selvaggi, Caitlin A.
    Lubitz, Steven A.
    Foulkes, Andrea S.
    Ho, Jennifer E.
    [J]. PLOS ONE, 2021, 16 (04):
  • [29] Modeling and Control of COVID-19 Transmission from a Perspective of Polymerization Reaction Dynamics
    Zhang, Chijin
    Liao, Zuwei
    Sun, Jingyuan
    Yang, Yao
    Wang, Jingdai
    Yang, Yongrong
    [J]. INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2021, 60 (48) : 17650 - 17662
  • [30] Transmission of varicella-zoster virus originating from a patient with localized herpes zoster: Implications for infection control?
    Cholongitas, Evangelos
    Ilonidis, George
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2010, 38 (08) : 669 - 670